Market research reports on: Pharmaceutical manufacture, cancer, oncology, prevention and treatment, therapeutics, vaccines, clinical studies, drug delivery, immunology, immunotherapy and others.
Let's ConnectNothing Degrading about Saving Lives: E3 Ligands Recruiting New D...
Posttranslational modifications hit prime time in the pharma industry. There probably isn’t a medium sized biopharmaceutical that does not have an active program ongoing, and certainly all of the big pharma companies are running multiple programs, and collaborations, for what we might have previously termed “undruggable targets”. Many of these are for highly unmet needs in neurodegeneration. The properties of the structure that forms between a target, a degrader and an E3 ligase, are under intense investigation. Minor changes affect how the drugs work - this can explain how promiscuous target-binding payloads can achieve super selectivity when transformed into a degrader. These minor alterations can also render the molecule complex not only ineffective, but sometimes toxic. However, clinical results are beginning to write a compellingly effective story – the long and winding history of research into the ubiquitin proteasome may well have more blockbusters in store for us. And cures in a once overlooked corner of the cell machinery architecture.
Colorectal Cancer Therapeutics: Global Markets
The global colorectal cancer therapeutics market should reach $18.5 billion by 2023 from $13.7 billion in 2018 at a compound annual growth rate (CAGR) of 6.1% for the period 2018 to 2023.
Blood Cancer Therapeutics: Global Markets to 2023
The global market for blood cancer therapeutics should grow from $38.5 billion in 2018 to $64.8 billion by 2023 at a compound annual growth rate (CAGR) of 11.0% from 2018 to 2023.
Opioid Drugs: Global Markets to 2023
The global market for opioid drugs should reach $29.8 billion by 2023 from $26.4 billion in 2018 at a compound annual growth rate (CAGR) of 2.5% for the period of 2018-2023.
Antibiotics: Global Markets to 2023
The global antibiotics market should reach $55.8 billion by 2023 from $38.3 billion in 2018 at a compound annual growth rate (CAGR) of 7.8% for the period of 2018-2023.
Lung Cancer Therapeutics: Global Markets
The global market for lung cancer therapeutics should grow from $17.9 billion in 2018 to $26.3 billion by 2023, increasing at a compound annual growth rate (CAGR) of 8.0% from 2018 to 2023.
Checkpoint Inhibitors: Global Markets
The global checkpoint inhibitors market should reach $29.3 billion by 2023 from $14.9 billion in 2018 at a compound annual growth rate (CAGR) of 14.4% for the period of 2018-2023.
Chromatography: A BCC Research Outlook
The global market for chromatography reagents should grow from $10.0 billion in 2018 to $14.2 billion by 2023 at a compound annual growth rate (CAGR) of 7.4% from 2018 through 2023.
Antipsychotic Drugs: Technologies and Global Markets
The global market for antipsychotic drugs should grow from $13.2 billion in 2018 to reach $14.5 billion by 2023 at a compound annual growth rate (CAGR) of 1.9% for the period of 2018-2023.
Lysosomal Disease Treatments: Technologies and Global Markets
The global market for lysosomal storage diseases treatment should grow from $5.1 billion in 2018 to reach $7.6 billion by 2023 at a compound annual growth rate (CAGR) of 8.3% for the period of 2018-2023.
Antiemetics: Technologies and Global Markets
The global market for antiemetics reached $4.1 billion in 2017 and should reach $5.9 billion by 2022, at a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2018-2023.
Cognition and Memory Enhancement Drugs: Technologies and Global M...
The global cognition and memory-enhancing drugs market should reach over $4.2 billion by 2022 from $2.8 billion in 2017 at a compound annual growth rate (CAGR) of 8.7% for the period 2017-2022.
Neuroprotective Agents: Therapeutic Applications and Global Marke...
The global market for neuroprotective agents will grow from $54.4 billion in 2017 to $75.8 billion by 2022 with a compound annual growth rate (CAGR) of 6.8% for the period of 2017-2022.
Antiulcerant Drugs: Global Markets to 2022
The global antiulcerant drugs market will grow from $33.0 billion in 2017 to $37.4 billion by 2022 with a compound annual growth rate (CAGR) of 2.5% for the period of 2017-2022.
Drugs for Urinary Incontinence and Overactive Bladder: Global Mar...
The global drugs for urinary incontinence and overactive bladder market should reach $4.2 billion by 2022 from $3.6 billion in 2017 at a compound annual growth rate (CAGR) of 2.9%, from 2017 to 2022.
Muscle Relaxants: Global Markets to 2022
The global muscle relaxants market totaled $18.4 billion in 2017 and is estimated to reach $24.4 billion by 2022, growing at a compound annual growth rate (CAGR) of 5.8% for the period of 2017-2022.
Anti-Epileptic Drugs: Global Markets to 2022
The global anti-epileptic drugs market totaled $8.4 billion in 2017 and is estimated to reach $9.5 billion by 2022, growing at a compound annual growth rate (CAGR) of 2.7% for the period of 2017-2022.
Drugs for Infertility: Global Markets to 2022
The global market for drugs for infertility should reach $4.2 billion by 2022 from $3.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.3%, from 2017 to 2022.
Small Molecule Therapies for Rheumatoid Arthritis: Global Markets...
The global small molecule therapies for rheumatoid arthritis market totaled $1.7 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 6.6% for the period of 2017-2022.
Cardiovascular Drugs: Global Markets to 2022
The global cardiovascular drugs market should reach $149.4 billion by 2022 from $141.1 billion in 2017 at a compound annual growth rate (CAGR) of 1.2%, from 2017 to 2022.
Substance Abuse and Addiction Treatment, Global Markets to 2021
The global substance abuse and addiction treatment market reached $3.1 billion in 2016 and should reach nearly $4.4 billion in 2021, at a compound annual growth rate (CAGR) of 7.0%.
The Chinese Market for Cancer Intervention
The Chinese cancer intervention market reached nearly $41.1 billion in 2016. This market should reach $46.7 billion in 2017 and $89.3 billion by 2022, at a compound annual growth rate (CAGR) of 13.8% through 2022.
Global Markets for Neglected Tropical Disease Treatments
The global market for neglected tropical diseases should reach $2.6 billion by 2021 from $1.4 billion in 2016 at a compound annual growth rate (CAGR) of 14.1%, from 2016 to 2021.
Smart Pills: Applications and Global Markets
The global market for smart pills reached $720 million in 2015. This market is expected to increase from $850 million in 2016 to $2.2 billion in 2021 at a compound annual growth rate (CAGR) of 21.1% for 2016-2021.
Infectious Disease Drugs: The Chinese Market
The Chinese infectious disease drugs market reached $32.2 billion in 2016. The market should reach $61.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 13.9% from 2016 to 2021.
Monoclonal Antibodies for Oncology: Global Markets
This report provides detailed exposure of global monoclonal antibodies for the oncology market. This report highlights the current and future market potential of monoclonal antibodies for oncology treatment and includes a detailed analysis of the market’s drivers, challenges, and opportunities. The report also covers market projections to 2030 and market share for key market players.
Global Bispecific Antibodies Market
This report provides an overview of the global bispecific antibodies market and analyzes market trends. It includes global revenue ($ million) for the base year data of 2024 and estimated data for the forecast period from 2025 through 2030.
Cardiovascular Drugs: Global Markets to 2030
This report provides detailed exposure of the cardiovascular drugs market, highlighting major cardiovascular diseases with detailed epidemiology for the primary disease areas. It includes an industrywide assessment of the novel product launches, recent approvals, R&D pipeline and blockbuster drugs.
Lung Cancer Therapeutics: Global Markets
This report will provide detailed information on the global market for lung cancer therapeutics. This report analyzes the market trends of lung cancer therapeutics with data from 2024, estimates from 2025, projections of compound annual growth rates through 2030, and regional markets of lung cancer therapeutics.
Radioligand Therapeutics in Cancer Treatment: Global Market
This report provides an analysis of radioligand therapeutics in cancer treatment market along with detailed profiles of key market players including a revenue product portfolio and recent activities. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030.
Neuroprotective Agents: Therapeutic Applications and Global Markets
This report provides an overview of the global market for neuroprotective agents and their therapeutic applications. It includes global revenue ($ Million) for the base year of 2024 and estimated data for 2025 and the forecast period 2026 through 2030.
Emerging Drugs: Global Markets
The report provides an overview of the global emerging drugs and analyzes market trends. It includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030. The market is based on molecule type, product type, therapeutic application, and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with a focus on major countries in these regions.
The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.
The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key players in the global Emerging Drugs Market. It also has a dedicated section of company profiles that covers details of leading key market players.
Substance Use Disorder Treatment: Global Market
This report presents an in-depth analysis of the global substance abuse and addiction treatment market. It provides market analyses by conditions, treatments, and geographic regions. The report includes the principal drug abuse conditions that are incorporated into several therapeutic treatment methods.
In Vitro Toxicity Testing: Technologies and Global Markets
This report provides an overview of the global in vitro toxicity testing market and analyzes market trends. It includes global revenue ($ Million) for base year data 2024 and estimated data for the forecast period 2025 through 2030.
Blood Cancer Therapeutics: Global Markets to 2030
The current report will provide detailed information on the global market for blood cancer therapeutics. This report analyzes the market trends of blood cancer therapeutics, providing data for 2024, estimates for 2025, projections of compound annual growth rates through 2030 (forecast period: 2025–2030), and regional markets for blood cancer therapeutics. This report provides an overview of blood cancer therapeutics, including current and future market potential, as well as a detailed analysis of the competitive landscape. The recent report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2030 and the market share for key market players.
The market scope in this report is segmented into types: leukemia, lymphoma, and multiple myeloma. The leukemia is further subdivided into acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelogenous (myeloid) leukemia (AML), and chronic myelogenous (myeloid) leukemia (CML).
The market has been segmented into significant geographies: North America, Europe, Asia-Pacific, the Middle East & Africa, and South America. The regional segment will provide a detailed analysis of major countries, including the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. For market estimates, data will be provided for 2024 as the base year, with forecasts for 2025 and a 2030 forecast value.
